{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:09:54Z","timestamp":1789002594321,"version":"build-2803163510"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01841","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T04:52:48Z","timestamp":1565067168000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Design and Development of a Novel Peptide for Treating Intestinal Inflammation"],"prefix":"10.3389","volume":"10","author":[{"given":"Lulu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim N.","family":"Petitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12257-014-0131-4","article-title":"Picrasma quassioides inhibits LPS- and IFN-\u03b3-stimulated nitric oxide production and inflammatory response in RAW264.7 macrophage cells","volume":"19","author":"Song","year":"2014","journal-title":"Biotechnol Bioproc E."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1210\/en.2004-1119","article-title":"Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets","volume":"146","author":"Burrin","year":"2005","journal-title":"Endocrinology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1136\/gut.35.11.1590","article-title":"Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis","volume":"35","author":"Gillen","year":"1994","journal-title":"Gut."},{"key":"B4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut."},{"key":"B5","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<;854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease - a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases - basic and clinical correlates","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.mad.2004.06.010","article-title":"Mechanisms of glucocorticoid receptor signaling during inflammation","volume":"125","author":"Smoak","year":"2004","journal-title":"Mech Ageing Dev."},{"key":"B10","first-page":"277","article-title":"Steroids, retinoids, and wound healing","volume":"11","author":"Anstead","year":"1998","journal-title":"Adv Wound Care."},{"key":"B11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/bjo.82.6.704","article-title":"Systemic corticosteroid therapy - side effects and their management","volume":"82","author":"Stanbury","year":"1998","journal-title":"Brit J Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3389\/fimmu.2018.01704","article-title":"Inhibition of lipopolysaccharide- and lipoprotein-induced inflammation by antitoxin peptide pep 19-2.5","volume":"9","author":"Heinbockel","year":"2018","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.4049\/jimmunol.1700985","article-title":"Mechanisms of the innate defense regulator peptide-1002 anti-inflammatory activity in a sterile inflammation mouse model","volume":"199","author":"Wu","year":"2017","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcp.2016.01.009","article-title":"Porcine lactoferrin-derived peptide LFP-20 protects intestinal barrier by maintaining tight junction complex and modulating inflammatory response","volume":"104","author":"Zong","year":"2016","journal-title":"Biochem Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bbrc.2008.02.105","article-title":"Interactions of a designed peptide with lipopolysaccharide: bound conformation and anti-endotoxic activity","volume":"369","author":"Bhunia","year":"2008","journal-title":"Biochem Bioph Res Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00726-017-2449-7","article-title":"The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities","volume":"49","author":"Mu","year":"2017","journal-title":"Amino Acids."},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","article-title":"A comprehensive summary of LL-37, the factotum human cathelicidin peptide","volume":"280","author":"Vandamme","year":"2012","journal-title":"Cell Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.15-17652","article-title":"Inhibition by the antimicrobial peptide LL37 of lipopolysaccharide-induced innate immune responses in human corneal fibroblasts","volume":"57","author":"Ishida","year":"2016","journal-title":"Invest Ophth Vis Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0147919","DOI":"10.1371\/journal.pone.0147919","article-title":"Immunomodulatory and anti-inflammatory activities of chicken cathelicidin-2 derived peptides","volume":"11","author":"van Dijk","year":"2016","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1159\/000354465","article-title":"Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo","volume":"32","author":"Hou","year":"2013","journal-title":"Cell Physiol Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF02786456","article-title":"Thymopentin and splenopentin as immunomodulators - current status","volume":"17","author":"Singh","year":"1998","journal-title":"Immunol Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1440-1746.2008.05387.x","article-title":"Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: a prospective randomized, comparative pilot study","volume":"23","author":"Lee","year":"2008","journal-title":"J Gastroenterol Hepatol."},{"key":"B23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0021-9258(17)37900-0","article-title":"The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus","volume":"254","author":"Low","year":"1979","journal-title":"J Biol Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1182\/blood-2006-02-004762","article-title":"Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance","volume":"108","author":"Romani","year":"2006","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.4305","article-title":"Thymosin \u03b11 represents a potential potent single-molecule-based therapy for cystic fibrosis","volume":"23","author":"Romani","year":"2017","journal-title":"Nat Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1155\/S1064744996000439","article-title":"Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses","volume":"4","author":"Mendling","year":"1996","journal-title":"Infect Dis Obstet Gynecol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"12351","DOI":"10.1038\/s41598-018-30956-y","article-title":"Thymosin alpha1-fc modulates the immune system and down-regulates the progression of melanoma and breast cancer with a prolonged half-life","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/sj.embor.7400433","article-title":"Activation of IKK by thymosin alpha 1 requires the TRAF6 signalling pathway","volume":"6","author":"Zhang","year":"2005","journal-title":"EMBO Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1182\/blood-2003-11-4036","article-title":"Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling","volume":"103","author":"Romani","year":"2004","journal-title":"Blood."},{"key":"B30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1196\/annals.1415.002","article-title":"Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance","volume":"1112","author":"Romani","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05465.x","article-title":"Thymosin alpha1: the regulator of regulators?","volume":"1194","author":"Pierluigi","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1134\/S0006350909020122","article-title":"Immunomodulatory effects of thymopentin under acute and chronic inflammations in mice","volume":"54","author":"Lunin","year":"2009","journal-title":"Biofizika."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.451537","article-title":"Synthetic pentapeptide with biological-activity characteristic of the thymic hormone thymopoietin","volume":"204","author":"Goldstein","year":"1979","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14712590902911412","article-title":"From lab to bedside: emerging clinical applications of thymosin alpha(1)","volume":"9","author":"Goldstein","year":"2009","journal-title":"Expert Opin Biol Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2018.04.235","article-title":"LL-37-induced human osteoblast cytotoxicity and permeability occurs independently of cellular LL-37 uptake through clathrin-mediated endocytosis","volume":"501","author":"Anders","year":"2018","journal-title":"Biochem Bioph Res Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.peptides.2015.03.015","article-title":"High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides","volume":"71","author":"Haney","year":"2015","journal-title":"Peptides."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/cbic.201402264","article-title":"Short antimicrobial lipo-\u03b1\/\u03b3-AA hybrid peptides","volume":"15","author":"Li","year":"2014","journal-title":"Chembiochem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.peptides.2005.09.016","article-title":"Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application","volume":"27","author":"Nell","year":"2006","journal-title":"Peptides."},{"key":"B39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.peptides.2012.04.004","article-title":"Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37","volume":"35","author":"Nan","year":"2012","journal-title":"Peptides."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0196-9781(98)00132-6","article-title":"The conformation of peptide thymosin alpha 1 in solution and in a membrane-like environment by circular dichroism and NMR spectroscopy. A possible model for its interaction with the lymphocyte membrane","volume":"19","author":"Grottesi","year":"1998","journal-title":"Peptides."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1021\/acs.biochem.5b01345","article-title":"Thymosin \u03b11 interacts with exposed phosphatidylserine in membrane models and in cells and uses serum albumin as a carrier","volume":"55","author":"Mandaliti","year":"2016","journal-title":"Biochemistry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1016\/j.biomaterials.2011.02.034","article-title":"Ternary complexes of amphiphilic polycaprolactone-graft-poly (N,N-dimethylaminoethyl methaaylate), DNA and polyglutamic acid-graft-poly (ethylene glycol) for gene delivery","volume":"32","author":"Guo","year":"2011","journal-title":"Biomaterials."},{"key":"B43","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/archsurg.1970.01340280036010","article-title":"Intestinal mucosal lesion in low-flow states. 2. protective effect of intraluminal glucose as energy substrate","volume":"101","author":"Chiu","year":"1970","journal-title":"Arch Surg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/gutjnl-2012-303731","article-title":"Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium","volume":"63","author":"Chen","year":"2014","journal-title":"Gut."},{"key":"B45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.dci.2015.05.006","article-title":"LFP-20, a porcine lactoferrin peptide, ameliorates LPS-induced inflammation via the MyD88\/NF-kappa B and MyD88\/MAPK signaling pathways","volume":"52","author":"Zong","year":"2015","journal-title":"Dev Comp Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J Comput Aid Mol Des."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J Comput Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald - an N.Log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys."},{"key":"B50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect Drug Discov."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1002\/eji.201141648","article-title":"Human \u03b2-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF","volume":"41","author":"Semple","year":"2011","journal-title":"Eur J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/prot.24223","article-title":"Lipid a from lipopolysaccharide recognition: Structure, dynamics and cooperativity by molecular dynamics simulations","volume":"81","author":"Garate","year":"2013","journal-title":"Proteins."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gut.2004.047092","article-title":"Increased gut permeability in Crohn's disease: is TNF the link?","volume":"53","author":"Gibson","year":"2004","journal-title":"Gut."},{"key":"B54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1051\/medsci\/2010264405","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"26","author":"Matricon","year":"2010","journal-title":"Med Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","article-title":"Obesity and the regulation of energy balance","volume":"104","author":"Spiegelman","year":"2001","journal-title":"Cell."},{"key":"B56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri2891","article-title":"Innate immune mechanisms of colitis and colitis-associated colorectal cancer","volume":"11","author":"Saleh","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1021\/jm950803a","article-title":"Stabilized analogs of thymopentin. 1. 4,5-ketomethylene pseudopeptides","volume":"40","author":"DeGraw","year":"1997","journal-title":"J Med Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.biomaterials.2012.09.032","article-title":"Design of hybrid \u03b2-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials."},{"key":"B59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.biomaterials.2015.02.063","article-title":"Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of \u03b1-helix-based peptide amphiphiles","volume":"52","author":"Ma","year":"2015","journal-title":"Biomaterials."},{"key":"B60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.tibs.2004.04.008","article-title":"MD-2: the Toll 'gatekeeper' in endotoxin signalling","volume":"29","author":"Gangloff","year":"2004","journal-title":"Trends Biochem Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.1139111","article-title":"Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa","volume":"316","author":"Ohto","year":"2007","journal-title":"Science."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/infdis\/jiq155","article-title":"MD-2 as the target of nonlipid chalcone in the inhibition of endotoxin LPS-induced TLR4 activity","volume":"203","author":"Roh","year":"2011","journal-title":"J Infect Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature."},{"key":"B64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.biotechadv.2011.05.014","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists","volume":"30","author":"Peri","year":"2012","journal-title":"Biotechnol Adv."},{"key":"B65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/BF02087693","article-title":"Neutrophil-independence of the initiation of colonic injury - comparison of results from 3 models of experimental colitis in the rat","volume":"39","author":"Buell","year":"1994","journal-title":"Digest Dis Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.intimp.2017.03.028","article-title":"Cholecystokinin protects mouse liver against ischemia and reperfusion injury","volume":"48","author":"Zhang","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.4049\/jimmunol.1402300","article-title":"Porcine \u03b2-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis","volume":"194","author":"Han","year":"2015","journal-title":"J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu Rev Biochem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"31291","DOI":"10.1074\/jbc.M200755200","article-title":"A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase","volume":"277","author":"Fessler","year":"2002","journal-title":"J Biol Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e104032","DOI":"10.1371\/journal.pone.0104032","article-title":"Protective effects of carbon monoxide-releasing molecule-2 on the barrier function of intestinal epithelial cells","volume":"9","author":"Mu","year":"2014","journal-title":"PLoS ONE."},{"key":"B72","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MPG.0b013e3181ae2ba0","article-title":"Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation","volume":"50","author":"Park","year":"2010","journal-title":"J Pediatr Gastr Nutr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.taap.2009.08.002","article-title":"Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization","volume":"241","author":"McCall","year":"2009","journal-title":"Toxicol Appl Pharm."},{"key":"B76","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2180-9-63","article-title":"L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells","volume":"9","author":"Qin","year":"2009","journal-title":"BMC Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00384-008-0544-7","article-title":"Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor-kappa B activation","volume":"24","author":"Zhang","year":"2009","journal-title":"Int J Colorectal Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappa B","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01841\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T03:31:21Z","timestamp":1610767881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01841\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2019.01841"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01841","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"article-number":"1841"}}